Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals

Molecular Therapy(2020)10.1016/j.ymthe.2020.11.007Source: DataRank Database

Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals is a research paper published in Molecular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.25)OA: hybridTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Julie K. Jadlowsky ORCID,Simon F. Lacey ORCID,Joseph A. Fraietta ORCID,Gabriela Plesa ORCID,Hideto Chono

Live enrichment

PubMed:33186691 PMC:PMC7854306 OpenAlex:https://openalex.org/W3105904364

National Institute of Allergy and Infectious Diseases

Grant: HL2/3

National Institute of Allergy and Infectious Diseases

Grant: HLCD4-CAT

Novartis

Grant: T32-AI007632

National Cancer Institute

Grant: P30-CA016520-44S3

NCI NIH HHS

Grant: P30 CA016520

NIAID NIH HHS

Grant: T32 AI007632

University of Pennsylvania

National Institutes of Health

Novartis Institutes for BioMedical Research

FWCI

0.25

Citation Percentile

0.5%

Citation Trend

2022

2023

2024

2025

hybridLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S1525001620306055/pdf

publisherhttp://www.cell.com/article/S1525001620306055/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001620306055?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001620306055?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2020.11.007

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionCytomegalovirus and herpesvirus researchCD4 Lymphocyte CountCD4-Positive T-LymphocytesDNA-Binding ProteinsEndoribonucleasesEscherichia coli ProteinsGenetic TherapyHIV InfectionsHIV-1Viral LoadVirus Replicationtat Gene Products, Human Immunodeficiency Virus

MeSH Terms

DNA-Binding ProteinsEndoribonucleasesVirus ReplicationGenetic TherapyCD4-Positive T-LymphocytesHIV-1HIV InfectionsCD4 Lymphocyte CountViral LoadEscherichia coli Proteinstat Gene Products, Human Immunodeficiency Virus

Keywords

CD8EndoribonucleaseVirologyVirusImmune systemGenetic enhancementTransgeneBiologyPopulationHuman immunodeficiency virus (HIV)ImmunologyMedicineGeneRNAGene therapyimmune therapyHIV infectionCd4 T LymphocyteMazf EndoribonucleaseTat-induced Transgene

Sustainable Development Goals

SDG 0: Good health and well-being

Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals

FAIR Checklist

Authors (16)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)